4.5 Review

Could live attenuated vaccines better control COVID-19?

期刊

VACCINE
卷 39, 期 39, 页码 5719-5726

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2021.08.018

关键词

COVID-19; SARS-CoV-2; Live attenuated vaccine; Vaccine

向作者/读者索取更多资源

There are concerns regarding the adverse effects of COVID-19 vaccines, such as fever from mRNA vaccines and pre-existing immunity against adenovirus vectored vaccines. Live attenuated vaccines have been considered effective as they closely mimic natural infection. New temperature-sensitive variants of SARS-CoV-2 may present potential as live attenuated vaccines, which could be optimized for different phases of the pandemic.
In an effort to control the COVID-19 pandemic, large-scale vaccination is being implemented in various countries using anti-SARS-CoV-2 vaccines based on mRNAs, adenovirus vectors, and inactivated viruses. However, there are concerns regarding adverse effects, such as the induction of fever attributed to mRNA vaccines and pre-existing immunity against adenovirus vectored vaccines or their possible involvement in the development of thrombosis. The induction of antibodies against the adenovirus vector itself constitutes another hindrance, rendering boosting vaccinations ineffective. Additionally, it has been questioned whether inactivated vaccines that predominantly induce humoral immunity are effective against newly arising variants, as some isolated strains were found to be resistant to the serum from COVID-19-recovered patients. Although the number of vaccinated people is steadily increasing on a global scale, it is still necessary to develop vaccines to address the difficulties and concerns mentioned above. Among the various vaccine modalities, live attenuated vaccines have been considered the most effective, since they closely replicate a natural infection without the burden of the disease. In our attempt to provide an additional option to the repertoire of COVID-19 vaccines, we succeeded in isolating temperature-sensitive strains with unique phenotypes that could serve as seeds for a live attenuated vaccine. In this review article, we summarize the characteristics of the currently approved SARS-CoV-2 vaccines and discuss their advantages and disadvantages. In particular, we focus on the novel temperature sensitive variants of SARS-CoV-2 that we have recently isolated, and their potential application as live attenuated vaccines. Based on a thorough evaluation of the different vaccine modalities, we argue that it is important to optimize usage not only based on efficacy, but also on the phases of the pandemic. Our findings can be used to inform vaccination practices and improve global recovery from the COVID19 pandemic. (c) 2021 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据